The five human herpesviruses are endemic in the population and are responsible for a variety of clinically significant diseases. These viruses establish life-long infections and four of the five have been associated etiologically with cancer in man. Successful intervention in the viral replicative cycle, latency and transformation will necessitate a better understanding of the functions of individual viral genes and the manner in which gene expression is regulated. The series of studies proposed herein in designed to further our understanding of the role of the immediate-early protein ICP4 in transcriptional regulation ad to identify the functional roles of other immediate-early proteins - ICPs 0, 22, 27 and 47 - in the replicative process. For this purpose, we will compare the properties of ICP4 produced by ts mutants defective in the pre-DNA synthetic (early) function of ICP4 and the newly-idenified post-DNA-synthetic (late) function of ICP4 with that of wild-type ICP4. Mutant and wild-type forms of ICP 4 will be compared with regard to patterns of phosphorylation, poly(ADP-ribosyl)ation, DNA-binding properties, association with other viral and cellular proteins and ability to induce cellular stress proteins - all properties associated with transcriptional regulation. These studies, combined with fine-mapping and sequencing of mutant and wild-type genes for ICP4, should lead to a better definition of the two functions of ICP4. Efforts will then be made to correlate the phenotypic properties of mutant and wild-type forms of ICP4 with ability of early and late mutants to activate transcription from chimeric genes containing selected immediate-early, early, and late viral promoter regulatory sequences. Mutations will also be introduced into these sequences in order to identify important sites recognized by wild-type ICP4. Studies of other immediate-early genes will include 1) genetic and phenotypic characterization of three noncomplementing ts mutants which map in or near the coding sequences for ICP27, 2) introduction of insertion, deletion and ts mutants into the genes for ICPs 0, 22, 27 and 47 by in vitro mutagenesis, and 3) isolation of extragenic suppressor mutations from ts mutants in essential immediate-early genes as a means of identifying other viral proteisn with which immediate-early proteins interact.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA020260-11
Application #
3165262
Study Section
Experimental Virology Study Section (EVR)
Project Start
1980-03-01
Project End
1989-12-31
Budget Start
1987-01-01
Budget End
1987-12-31
Support Year
11
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Mostafa, Heba H; Thompson, Thornton W; Kushnir, Anna S et al. (2011) Herpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation. J Virol 85:12631-7
Kushnir, Anna S; Davido, David J; Schaffer, Priscilla A (2010) Role of nuclear factor Y in stress-induced activation of the herpes simplex virus type 1 ICP0 promoter. J Virol 84:188-200
Bowman, J Jason; Schaffer, Priscilla A (2009) Origin of expression of the herpes simplex virus type 1 protein U(S)1.5. J Virol 83:9183-94
Bowman, J Jason; Orlando, Joseph S; Davido, David J et al. (2009) Transient expression of herpes simplex virus type 1 ICP22 represses viral promoter activity and complements the replication of an ICP22 null virus. J Virol 83:8733-43
Boutell, Chris; Everett, Roger; Hilliard, Joshua et al. (2008) Herpes simplex virus type 1 ICP0 phosphorylation mutants impair the E3 ubiquitin ligase activity of ICP0 in a cell type-dependent manner. J Virol 82:10647-56
Bringhurst, Ryan M; Dominguez, Antonia A; Schaffer, Priscilla A (2008) Glutamine deprivation causes enhanced plating efficiency of a herpes simplex virus type 1 ICP0-null mutant. J Virol 82:11472-5
Orlando, Joseph S; Balliet, John W; Kushnir, Anna S et al. (2006) ICP22 is required for wild-type composition and infectivity of herpes simplex virus type 1 virions. J Virol 80:9381-90
Bringhurst, Ryan M; Schaffer, Priscilla A (2006) Cellular stress rather than stage of the cell cycle enhances the replication and plating efficiencies of herpes simplex virus type 1 ICP0- viruses. J Virol 80:4528-37
Davido, David J; von Zagorski, William F; Lane, William S et al. (2005) Phosphorylation site mutations affect herpes simplex virus type 1 ICP0 function. J Virol 79:1232-43
Davido, David J; Von Zagorski, William F; Maul, Gerd G et al. (2003) The differential requirement for cyclin-dependent kinase activities distinguishes two functions of herpes simplex virus type 1 ICP0. J Virol 77:12603-16

Showing the most recent 10 out of 30 publications